Avantor, Inc.
Health
Performance
8.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Avantor, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

16.01.2026
Pulse detected. Still fragile, but stabilizing.
01.01.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
15.11.2025
Red alert. Risk levels out of control.

Avantor, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Avantor, Inc. do? Business model and key facts

Get the full picture of Avantor, Inc.: what it builds, where it operates, and how it makes money.

Avantor, Inc. Profile

Sector: Healthcare

Industry: Medical - Instruments & Supplies

Employees (FY): 13500

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

shop
Company facts
Emmanuel Ligner
CEO
13500
Employees worldwide
shop
Performance
-44.76%
Last 12 months
-58.48%
Last 5 years
shop
Growth
$6,78B
Revenue year
$711,50M
Net income
shop
Valuation
$8,20B
Market Cap
20.15
Price/Earnings Ratio

Stocks related to Avantor, Inc.

Selected based on industry alignment and relative market positioning.

ATR
AptarGroup, Inc.
125.11
-1.37%
5.3
Sell
Buy
AptarGroup, Inc.
RGEN
Repligen Corporation
161.69
-0.21%
6.6
Sell
Buy
Repligen Corporation
BAX
Baxter International Inc.
20.37
+2.67%
6.9
Sell
Buy
Baxter International Inc.
MASI
Masimo Corporation
139.87
+1.05%
6.1
Sell
Buy
Masimo Corporation
BLCO
Bausch + Lomb Corporation
17.44
+0.69%
4.1
Sell
Buy
Bausch + Lomb Corporation

Avantor, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.